PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportslymphangioleiomyomatosis
MeSH D018192 - lymphangioleiomyomatosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008203:Lymphangiomyoma
0 Companies
0 Drugs
Success rate
D054973:Perivascular epithelioid cell neoplasms
0 Companies
0 Drugs
Success rate
D018192: 
Lymphangioleiomyomatosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
57%
8/14
Phase 2
13%
2/15
Phase 3
0%
0/2
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use